The following is a release fro m the Cannabis Licensing Authority (CLA) and does not necessarily align with the views of this blog:
As Jamaica develops its cannabis industry, of utmost importance has been to adhere to
regulations which have been set with close guidance to the international treaties.
In so doing, it seeks to maintain the transparency and integrity needed to assure international
confidence which aids in promoting exports from Jamaica and develop confidence from the
To guarantee a reputable medical cannabis industry, there needs to be an assurance for the
consumer that cannabis products are safe, properly labelled and packaged and provided by
reputable sources. This requirement is no different than that of any other medical products.
Jamaica’s closed loop system, ensures the maintenance of a legal framework in which
persons may access medicinal cannabis that is tested and safe for consumption.
Within the supply chain, each licensee is required to conduct transactions only with those who
are also in possession of a licence.
As such, if a processor wishes to make a product for sale, they must acquire cannabis from a
licensed cultivator, and then have this transported by a licensed transporter. To sell their
product in a retail setting, they must have a buyer, who is able to sell in a licensed retail
facility. For an individual to purchase the product for medicinal use, they must be in
possession of a medical prescription allowing them to consume.
The development and adherence to the closed loop system, also protects the general
populace by minimizing the opportunities for the illicit ganja trade to grow, despite the
development of legal channels for the growing, transportation, research, processing and
selling of the plant.